PECAM1 and neoplasm: To assess the antitumor effects of α1(IV)NC1 and its ability to activate microvasculature apoptosis, control and α1(IV)NC1 treated mice tumor sections were stained with anti-CD31 antibody (Fig. 6, middle panel).